ALWIS attended the 3rd America Drug Safety & AI Conference 2025 – Dec. 9-10, 2025 in San Diego, where our founder, Mr Abdul Rahim presented on key considerations for qualifying AI solutions in Pharmacovigilance.

The session highlighted the challenges AI systems pose in life science including pharmacovigilance environments and discussed practical approaches to ensuring compliance, reliability, and real-world usability. We also shared insights on how these principles are embedded within ALWIS’ flagship pharmacovigilance solutions, leveraging AI, ML, and advanced automation.

Our participation reflects ALWIS continued focus on delivering responsible, innovative AI-driven solutions for the life sciences and pharmacovigilance industry.